Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
RVMD
Stock Latest News
Ratings
Daraxonrasib Poised to Become Pancreatic Cancer Standard of Care on Strong RASolute 302 Outlook and Accelerated Launch Path
4d ago
RVMD
Premium
The Fly
Erasca price target raised to $20 from $10 at Stifel
5d ago
ERAS
RVMD
Premium
Company Announcements
Revolution Medicines Doubles Down on Costly RAS Push
12d ago
RVMD
Premium
The Fly
Revolution Medicines put volume heavy and directionally bearish
16d ago
RVMD
Premium
The Fly
Revolution Medicines assumed with a Buy at UBS
16d ago
RVMD
Premium
The Fly
Tango Therapeutics weakness an ‘over reaction,’ says Stifel
17d ago
BMY
RVMD
Premium
The Fly
Revolution Medicines price target lowered to $140 from $143 at Mizuho
17d ago
RVMD
Premium
The Fly
Revolution Medicines price target raised to $120 from $75 at Piper Sandler
17d ago
RVMD
Premium
The Fly
Revolution Medicines price target raised to $115 from $109 at BofA
17d ago
RVMD
Premium
The Fly
Revolution Medicines price target raised to $144 from $100 at Wells Fargo
17d ago
RVMD
Premium
Ratings
Revolution Medicines: Advancing RAS Inhibitor Pipeline and Strong Cash Runway Support Buy Rating
17d ago
RVMD
Premium
The Fly
Revolution Medicines reports Q4 EPS ($1.86), consensus ($1.56)
18d ago
RVMD
Premium
The Fly
Revolution Medicines sees FY26 operating expenses $1.6B-$1.7B
18d ago
RVMD
Premium
The Fly
Revolution Medicines initiated with an Outperform at Evercore ISI
18d ago
RVMD
Premium
Pre-Earnings
Is RVMD a Buy, Before Earnings?
20d ago
RVMD
Premium
The Fly
Revolution Medicines placed on ‘Positive Catalyst Watch’ at JPMorgan
26d ago
RVMD
Premium
The Fly
Revolution Medicines put volume heavy and directionally bearish
1M ago
RVMD
Premium
The Fly
Revolution Medicines price target raised to $122 from $92 at JPMorgan
1M ago
RVMD
Premium
The Fly
Revolution Medicines doses first patient in trial evaluating RMC-5127
1M ago
RVMD
Premium
The Fly
Revolution Medicines price target raised to $150 from $75 at Oppenheimer
2M ago
RVMD
Premium
Ratings
Revolution Medicines: Differentiated RAS(ON) Pipeline Underpins Overweight/Buy Rating and $92 December 2026 Target
2M ago
RVMD
Premium
The Fly
Revolution Medicines falls -17.1%
2M ago
RVMD
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
